{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:28:52Z","timestamp":1790270932640,"version":"4.1.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asian J Transfus Sci"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/ajts.ajts_67_17","type":"journal-article","created":{"date-parts":[[2020,12,19]],"date-time":"2020-12-19T13:48:23Z","timestamp":1608385703000},"page":"187","source":"Crossref","is-referenced-by-count":6,"title":["Severe drug-induced immune hemolysis due to ceftriaxone"],"prefix":"10.4103","volume":"14","author":[{"given":"RaviC","family":"Dara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0973-6247.304039-1","first-page":"1","volume-title":"Drug-induced immune hemolytic anemia and\/or positive direct antiglobulin tests","author":"Garratty","year":"1985","journal-title":"Immunohematology"},{"key":"key-10.4103\/0973-6247.304039-2","first-page":"66","volume-title":"Drugs that have been shown to cause drug-induced immune hemolytic anemia or positive direct antiglobulin tests: Some interesting findings since 2007","author":"Garratty","year":"2014","journal-title":"Immunohematology"},{"key":"key-10.4103\/0973-6247.304039-3","first-page":"85","volume-title":"How we investigate drug-induced immune hemolytic anemia","author":"Leger","year":"2014","journal-title":"Immunohematology"},{"key":"key-10.4103\/0973-6247.304039-4","first-page":"44","volume-title":"Drug-induced immune hemolytic anemia: The last 30 years of changes","author":"Arndt","year":"2014","journal-title":"Immunohematology"},{"key":"key-10.4103\/0973-6247.304039-5","first-page":"216","volume-title":"Ceftriaxone-induced hemolytic anemia in a child successfully managed with intravenous immunoglobulin","author":"Vehapo\u011flu","year":"2016","journal-title":"Turk J Pediatr"},{"key":"key-10.4103\/0973-6247.304039-6","first-page":"602","volume-title":"Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia","author":"Arndt","year":"2012","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.304039-7","first-page":"431","volume-title":"Ceftriaxone-induced hemolytic anemia in a Jehovah's Witness","author":"Tasch","year":"2017","journal-title":"Am J Case Rep"},{"key":"key-10.4103\/0973-6247.304039-8","first-page":"133","volume-title":"Ceftriaxone-induced immune hemolytic anemia as a life-threatening complication of antibiotic treatment of 'Chronic Lyme disease'","author":"De","year":"2017","journal-title":"Acta Clin Belg"},{"key":"key-10.4103\/0973-6247.304039-9","first-page":"A8054","volume-title":"Ceftriaxone-induced immune haemolytic anaemia and multi-organ failure","author":"Mulkens","year":"2015","journal-title":"Ned Tijdschr Geneeskd"}],"container-title":["Asian Journal of Transfusion Science"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:52:22Z","timestamp":1786733542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.AJTS_67_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"alternative-id":["304039"],"URL":"https:\/\/doi.org\/10.4103\/ajts.ajts_67_17","relation":{},"ISSN":["0973-6247"],"issn-type":[{"value":"0973-6247","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}